shot-button
E-paper E-paper
Home > News > India News > Article > Manmohan Singh stable had developed reaction to medication

Manmohan Singh stable, had developed reaction to medication

Updated on: 11 May,2020 01:10 PM IST  |  New Delhi
IANS |

"He is being investigated to rule out other causes of fever and is being provided care as needed. He is stable and under care of a team of doctors at AIIMS," the source said

Manmohan Singh stable, had developed reaction to medication

Manmohan Singh

Former Prime Minister Manmohan Singh, who was admitted to Delhi's All India Institute of Medical Sciences (AIIMS) after he developed a reaction to new medication and is stable, sources said on Monday.


Singh was brought to the AIIMS on Sunday at 8.45 p.m. According to the AIIMS sources, Singh was admitted for observation, investigation after he developed a febrile reaction to the new medication.


"He is being investigated to rule out other causes of fever and is being provided care as needed. He is stable and under care of a team of doctors at AIIMS," the source said.


The senior Congress leader is under the supervision of doctor Nitish Nayak. Singh has been kept under observation at the Intensive Care Unit (ICU).

In 2009, Singh underwent a successful coronary bypass surgery at the AIIMS, a complex beating-heart operation that took nearly 14 hours.

Catch up on all the latest Crime, National, International and Hatke news here. Also download the new mid-day Android and iOS apps to get latest updates.

Mid-Day is now on Telegram. Click here to join our channel (@middayinfomedialtd) and stay updated with the latest news

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK